Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19Shuchi Gulati, Yu Shyr, Chih–Yuan Hsu et al.|JAMA Oncology|2023Cited by 10
Resistance to CD19 Immunotherapy in B-Cell ALL Is Associated with Loss of CD19 and CD22 and an Enhanced Vulnerability to B Cell Receptor Signaling InhibitionSarah Aminov, Amit Verma, Bonnie Yates et al.|Blood|2022Cited by 3